Research on the midterm efficacy and prognosis of patients with diffuse large B-cell lymphoma by different evaluation methods in interim PET/CT
Xingying Li(First Affiliated Hospital of Zhengzhou University), Mingzhi Zhang(Chinese Academy of Sciences), Zhaoming Li(First Affiliated Hospital of Zhengzhou University), Xiaolong Wu(First Affiliated Hospital of Zhengzhou University), Xinli Xie(First Affiliated Hospital of Zhengzhou University), Xin Li(Union Hospital), Xinhua Wang(Zhengzhou University), Lei Zhang(First Affiliated Hospital of Zhengzhou University), Jingjing Wu(Beijing Tian Tan Hospital), Jiaqin Yan(First Affiliated Hospital of Zhengzhou University), Zhenchang Sun(First Affiliated Hospital of Zhengzhou University), Hui Yu(First Affiliated Hospital of Zhengzhou University), Xiaorui Fu(First Affiliated Hospital of Zhengzhou University), Yu Chang(Jilin University), Xudong Zhang(First Affiliated Hospital of Zhengzhou University), Feifei Nan(First Affiliated Hospital of Zhengzhou University), Tian Li(Xuzhou Central Hospital), Ling Li(First Affiliated Hospital of Zhengzhou University), Zhi‐Yuan Zhou(Tsinghua University)
Cited by 14
Related Papers
Participation and yield of a population-based colorectal cancer screening programme in China
|Gut|2018|409
PD-1/PD-L1 Blockade: Have We Found the Key to Unleash the Antitumor Immune Response?
|Frontiers in Immunology|2017|296
RIP1 Kinase Drives Macrophage-Mediated Adaptive Immune Tolerance in Pancreatic Cancer
|Cancer Cell|2018|251
Acalabrutinib (ACP-196): a selective second-generation BTK inhibitor
|Journal of Hematology & Oncology|2016|250
The genome of Mesobuthus martensii reveals a unique adaptation model of arthropods
|Nature Communications|2013|233